Antimicrobial
发表于 2025-3-28 15:07:06
Die Technik der kystoskopischen Untersuchunglls (Perez et al. 1985; Staerz et al. "CR60">1985). In vitro, this approach was extremely potent, highlighting the superiority of T-cell-induced compared to accessory cell-mediated killing. But two major drawbacks hampered the rapid transition of this new approach from preclinical investigations to successful clinical trials and market approval.
AMOR
发表于 2025-3-28 21:00:33
Roland E. KontermannPresents the recent advances in antibody engineering and in the various clinical applications.An invaluable resource for both experts and those new to the field.With contributions by international exp
口诀
发表于 2025-3-29 02:37:45
http://reply.papertrans.cn/19/1889/188886/188886_43.png
Nausea
发表于 2025-3-29 05:52:26
http://reply.papertrans.cn/19/1889/188886/188886_44.png
手段
发表于 2025-3-29 11:15:19
978-3-642-43207-1Springer-Verlag Berlin Heidelberg 2011
秘传
发表于 2025-3-29 12:14:25
http://reply.papertrans.cn/19/1889/188886/188886_46.png
Blemish
发表于 2025-3-29 17:32:47
,Ernährung und Ernährungsstörungen, can be further improved by protein and/or glyco-engineering (Carter 2006; Kubota et al. 2009). However, natural antibodies also face certain limitations. For example, antibodies are not capable of recruiting T cells because these cells do not express Fc receptors. Also, monoclonal antibodies are mo
bisphosphonate
发表于 2025-3-29 21:34:53
http://reply.papertrans.cn/19/1889/188886/188886_48.png
blithe
发表于 2025-3-30 01:46:39
Die Symmetrieeigenschaften der Kristalle,em as ideal building blocks to elaborate multivalent and/or multispecific molecules. This chapter aims at giving an overview of the published work using single domain antibodies to create bispecific antibodies.
克制
发表于 2025-3-30 06:18:09
Pathologie der Harnleitermündungvation of T-cell proliferation and cytotoxicity in vivo..This design allows easy engineering of multispecificity in a single molecule, e.g., bispecific antibodies bivalent for the target and monovalent for effector activation (e.g., for T-cell activation), or trispecific antibodies ..